RT @HLIStPauls: Dr. Don Sin et. al. investigated the IgG subclass deficiency in COPD in "Serum IgG subclass levels and risk of exacerbation…
Congrats on your recent publication Dr. Sin et al! https://t.co/a7Lxj5IYoF
RT @HLIStPauls: Dr. Don Sin et. al. investigated the IgG subclass deficiency in COPD in "Serum IgG subclass levels and risk of exacerbation…
RT @HLIStPauls: Dr. Don Sin et. al. investigated the IgG subclass deficiency in COPD in "Serum IgG subclass levels and risk of exacerbation…
Dr. Don Sin et. al. investigated the IgG subclass deficiency in COPD in "Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD" which was recently published in Respiratory Research. https://t.co/vlzkgBLYz4
RT @RespiratoryBMC: New: Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with #COPD https://t.co/RbVV9…
RT @RespiratoryBMC: New: Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with #COPD https://t.co/RbVV9…
RT @RespiratoryBMC: New: Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with #COPD https://t.co/RbVV9…
RT @RespiratoryBMC: New: Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with #COPD https://t.co/RbVV9…
RT @RespiratoryBMC: New: Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with #COPD https://t.co/RbVV9…
#respiratoryresearch Serum IgG subclass levels and risk of exacerbations and… https://t.co/1UANoAklXW
New: Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with #COPD https://t.co/RbVV9FUukR